Elisa Roca

Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study

Alessandro Russo, Marco Russano, Tindara Franchina et al. · Advances in Therapy · 2020 · 165 citations

Medicine, Immunology, Hematology +9

Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: prediction of the response to the first-line chemotherapy

Marco Ravanelli, Davide Farina, Mauro Morassi et al. · European Radiology · 2013 · 121 citations

Computed Tomography, First-line Chemotherapy, Contrast-enhanced Computed Tomography +13

Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations

Francesco Passiglia, Federico Cappuzzo, Oscar Alabiso et al. · British Journal of Cancer · 2018 · 85 citations · Full text

Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario

Luca Cantini, Giulia Mentrasti, Gian Luigi Russo et al. · ESMO Open · 2022 · 62 citations · Full text

CT texture analysis for prediction of EGFR mutational status and ALK rearrangement in patients with non-small cell lung cancer

Giorgio Maria Agazzi, Marco Ravanelli, Elisa Roca et al. · La radiologia medica · 2021 · 61 citations

Ct Texture Analysis, Medical Imaging, Egfr Mutational Status +12